The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation

Immunology and Cell Biology

Volumn 88, Issue 5, 2010, Pages 515-522

  Jacobsen, Johanne T ^a   Lunde, Elin ^a   Sundvold Gjerstad, Vibeke ^a   Munthe, Ludvig A ^a   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

B cells; B to T cell collaboration; idiotypic network; immune regulation; immunoglobulins; T cells

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; BREAKPOINT CLUSTER REGION PROTEIN; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN D; IMMUNOGLOBULIN IDIOTYPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COMMUNICATION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOREGULATION; MOUSE; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; UPREGULATION; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN PRESENTATION; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL COMMUNICATION; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN IDIOTYPES; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSFECTION;

EID: 77954312704     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.118     Document Type: Article

References (57)

1. Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575-581.
2. Kunkel HG, Mannik M, Williams RC. Individual antigenic specificity of isolated antibodies. Science 1963; 140: 1218-1219.
3. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 125C: 373-389.
4. Oak S, Gilliam LK, Landin-Olsson M, Torn C, Kockum I, Pennington CR et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci USA 2008; 105: 5471-5476.
5. Hernandez AM, Toledo D, Martinez D, Grinan T, Brito V, Macias A et al. Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody. J Immunol 2008; 181: 6625-6634.
6. Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10: 72-79.
7. Yang J, Bautz DJ, Lionaki S, Hogan SL, Chin H, Tisch RM et al. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 2008; 74: 1159-1169.
8. Cosenza H, Augustin AA, Julius MH. Idiotypes and anti-idiotypes as probes in analysis of immunoregulation. Cold Spring Harb Symp Quant Biol 1977; 41(Part 2): 709-718.
9. Schrater AF, Goidl EA, Thorbecke GJ, Siskind GW. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. III. Absence in nu/nu mice: evidence for T-cell dependence of the anti-idiotypic-antibody response. J Exp Med 1979; 150: 808-817.
10. Bogen B, Malissen B, Haas W. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur J Immunol 1986; 16: 1373-1378.
11. Saeki Y, Chen JJ, Shi LF, Okuda Y, Kohler H. Idiotype-specific T helper clones recognize a variable H chain determinant. J Immunol 1990; 144: 1625-1628.
12. Eyerman MC, Zhang X, Wysocki LJ. T cell recognition and tolerance of antibody diversity. J Immunol 1996; 157: 1037-1046.
13. Mitchison NA. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol 1971; 1: 18-27.
14. Lanzavecchia A. Antigen-specific interaction between Tand B cells. Nature 1985; 314: 537-539.
15. Jorgensen T, Hannestad K. Specificity of T and B lymphocytes for myeloma protein 315. Eur J Immunol 1977; 7: 426-431.
16. Rudensky AY, Mazel SM, Blechman JM, Yurin VL. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones. Eur J Immunol 1990; 20: 1691-1696.
17. Lunde E, Munthe LA, Vabo A, Sandlie I, Bogen B. Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells. Nat Biotechnol 1999; 17: 670-675.
18. Weiss S, Bogen B. B-lymphoma cells process and present their endogenous immu-noglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 1989; 86: 282-286.
19. Weiss S, Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell 1991; 64: 767-776.
20. Bogen B, Weiss S. Processing and presentation of idiotypes to MHC-restricted T cells. Int Rev Immunol 1993; 10: 337-355.
21. Munthe LA, Kyte JA, Bogen B. Resting small B cells present endogenous immunoglo-bulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo. Eur J Immunol 1999; 29: 4043-4052.
22. Munthe LA, Os A, Zangani M, Bogen B. MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B Cell receptor ligation facilitates switch to IgG production. J Immunol 2004; 172: 7476-7484.
23. Snyder CM, Zhang X, Wysocki LJ. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells. J Immunol 2002; 168: 3865-3873.
24. Snyder CM, Aviszus K, Heiser RA, Tonkin DR, Guth AM, Wysocki LJ. Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region. J Exp Med 2004; 200: 1-11.
25. Bogen B, Lambris JD. Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. EMBO J 1989; 8: 1947-1952.
26. Bogen B, Gleditsch L, Weiss S, Dembic Z. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities. Eur J Immunol 1992; 22: 703-709.
27. Kristoffersen G, Hannestad K, Hansen T. Two M315 idiotopes defined by isologous monoclonal antibodies: one depends on germline and the other on mutated murine lambda 2 light chain sequences. Scand J Immunol 1987; 26: 535-546.
28. Turner M, Billadeau DD. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat Rev Immunol 2002; 2: 476-486.
29. Lundin KU, Screpanti V, Omholt H, Hofgaard PO, Yagita H, Grandien A et al. CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo. Cancer Immunol Immunother 2004; 53: 1135-1145.
30. Lauritzsen GF, Weiss S, Bogen B. Anti-tumour activity of idiotype-specific, MHC-restricted Th1 and Th2 clones in vitro and in vivo. Scand J Immunol 1993; 37: 77-85.
31. Lundin KU, Hofgaard PO, Omholt H, Munthe LA, Corthay A, Bogen B. Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. Blood 2003; 102: 605.
32. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991; 145: 185-192.
33. Snodgrass HR, Fisher AM, Bruyns E, Bogen B. Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences. Eur J Immunol 1992; 22: 2169-2172.
34. Kristoffersen G, Hannestad K. Immune responses to an adjuvant-free native syngeneic myeloma protein (M315). Eur J Immunol 1988; 18: 1785-1790.
35. Tisch R, Watanabe M, Letarte M, Hozumi N. Assessment of antigen-specific receptor function of surface immunoglobulin M and D with identical hapten specificity. Proc Natl Acad Sci USA 1987; 84: 3831-3835.
36. Goding JW, Scott DW, Layton JE. Genetics, cellular expression and function of IgD and IgM receptors. Immunol Rev 1977; 37: 152-186.
37. Munthe LA, Corthay A, Os A, Zangani M, Bogen B. Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells. J Immunol 2005; 175: 2391-2400.
38. Zangani M, Carlsen H, Kielland A, Os A, Hauglin H, Blomhoff R et al Tracking early autoimmune disease by bioluminescent imaging of NF-\{kappa\}B activation reveals pathology in multi. Am J Pathol 2009; 174: 1358-1367.
39. Zangani MM, Froyland M, Qiu GY, Meza-Zepeda LA, Kutok JL, Thompson KM et al. Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med 2007; 204: 1181-1191.
40. Odermatt BF, Perlmutter R, Lynch RG. Molecular heterogeneity and fine specificity of BALB/c antibodies elicited by isologous myeloma protein. Eur J Immunol 1978; 8: 858-865.
41. Seppala IJ, Eichmann K. Induction and characterization of isogeneic anti-idiotypic antibodies to BALB/c myeloma S117: lack of reactivity with major idiotypic determinants. Eur J Immunol 1979; 9: 243-250.
42. Sato K, Ochi A. Superclustering of B cell receptor and Fc gamma RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1. J Immunol 1998; 161: 2716-2722.
43. Bogen B, Jorgensen T, Hannestad K. T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region. Eur J Immunol 1985; 15: 278-281.
44. Bogen B, Dembic Z, Weiss S. Clonal deletion of specific thymocytes by an immunoglo-bulin idiotype. EMBO J 1993; 12: 357-363.
45. Bogen B, Snodgrass R, Briand JP, Hannestad K. Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. Eur J Immunol 1986; 16: 1379-1384.
46. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997; 90: 1073-1083.
47. Bogen B, Munthe L, Sollien A, Hofgaard P, Omholt H, Dagnaes F et al. Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies. Eur J Immunol 1995; 25: 3079-3086.
48. Goetzl EJ, Metzger H. Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide. Biochemistry 1970; 9: 1267-1278.
49. Lunde E, Bogen B, Sandlie I. Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells. Mol Immunol 1997; 34: 1167-1176.
50. Norderhaug L, Olafsen T, Michaelsen TE, Sandlie I. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods 1997; 204: 77-87.
51. Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 1979; 122: 549-554.
52. Bogen B. Monoclonal antibodies specific for variable and constant domains of murine lambda chains. Scand J Immunol 1989; 29: 273-279.
53. Bogen B, Lauritzsen GF, Weiss S. A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones. Eur J Immunol 1990; 20: 2359-2362.
54. Kung JT, Sharrow SO, Sieckmann DG, Lieberman R, Paul WE. A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. J Immunol 1981; 127: 873-876.
55. Baniyash M, Eshhar Z. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur J Immunol 1984; 14: 799-807.
56. Yelton DE, Desaymard C, Scharff MD. Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma 1981; 1: 5-11.
57. Granum S, Andersen TC, Sorlie M, Jorgensen M, Koll L, Berge T et al. Modulation of Lck function through multisite docking to T cell-specific adapter protein. J Biol Chem 2008; 283: 21909-21919.